International Conference on Immunotherapy/Radiotherapy Combinations – 4th edition

12th – 14th Sep. 2019 - ImmunoRad - New York, Weill Cornell Medicine

4th International Conference on Immunotherapy Radiotherapy Combination

picto ticket Click here for registration

International Conference on Chromosomal Translocations – 1st edition

20th- 21st May 2019 – Chromosomal Translocations – Paris, Institut Pasteur

1st International Conference on Mechanisms and Consequences of Chromosomal Translocations

picto ticket Click here for registration

SOCRATE 2.0 repart pour 3 ans

Gustave Roussy continue l’aventure SIRIC avec SOCRATE 2.0 !

Sélectionné suite à l’appel d’offre SIRIC-2 de l’INCa, le projet SOCRATE 2.0 de Gustave Roussy repart pour 3 ans avec une gouvernance et un programme scientifique remaniés. Seul bémol à l’horizon: le budget ainsi que la période de labellisation sont très largement amputés et la participation de la DGOS reste incertaine à ce jour. Cette absence de visibilité budgétaire va rendre la gestion du programme plus compliquée que lors de la première période. Consultez la liste des SIRICs ici http://www.e-cancer.fr/Institut-national-du-cancer/Appels-a-projets/Appels-a-projets-resultats/SIRIC-2017

Les médecins-chercheurs de Gustave Roussy apportent la preuve de l'intérêt des analyses génomiques à haut débit dans le cancer

Cancer discovery

Dans une étude publiée le 1er avril 2017 dans la prestigieuse revue Cancer Discovery, les équipes de recherche de Gustave Roussy, de l'INSERM et de l'Université Paris-Sud démontrent que l'analyse du portrait moléculaire de la tumeur cancéreuse permet d'identifier la thérapie adaptée et d'améliorer le pronostic des patients face au cancer.

Read more...

2nd International Symposium of the Cancer Research Center of Lyon

Un colloque scientifique international sur la génétique et la génomique des cancers

Du 21 au 23 septembre 2015 International Symposium

Cette seconde édition sera axée sur « The tumor and its Microenvironment: Challenges and Innovative Therapies »

IMPORTANT DEADLINES:

May 27th, 2015: Deadline for abstract submission
July 23rd, 2015: Deadline for early bird registration

Read more...

STEERING COMMITEE

CORE MANAGEMENT of SIRIC SOCRATE 2.0

E.Deutsch
A.Bobard
vide 
 
Eric DEUTSCH
Director
 
Alexandre BOBARD
Manager
Pierre BEUCHET
Financial Administrator

GRCC Institutional and patient representatives

E.Solary
G.vassal
O.Lecomte
Eric SOLARY
Research Director
Gilles VASSAL
Clinical Research Director
Olivier LECOMTE
Patient representative
 

Program 1: DDR

 

Program 2: I-O

 

Program 3: CMD

 
 
 
 
 
vide
S.postel vinay
 
L.Zitvogel
A.marabelle
 
O.bernard
F.Andre
Patricia KARNOUCHE |
Sophie POSTEL-VINAY
  Laurence Zitvogel |
Aurelien MARABELLE  
Olivier BERNARD |
Fabrice ANDRE

 

The Director, the Manager, the work-package leaders of SIRIC SOCRATE and the Director of Gustave Roussy Research department are composing the steering committee. According to the topics, invited speakers are sometimes invited to contribute to the debate and share their experience to push forward the SOCRATE project. This monthly meeting allows for the assessment of the actions, the definition of new directions, adjustments, recruitments and investments needed to ensure the scientific and administrative consistence of the SOCRATE project.

SOCRATE PRESENTATION

siric-visuel-accueilThe SOCRATE program

The SOCRATE program covers three areas of research involving the integration of basic with translational and clinical research as well as social sciences on the same site. Every work-packages are co-directed by a clinician researcher and a fundamental researcher : the SOCRATE project aims at breaking barriers between clinical and basic research. This innovative structuration has the ambition to boost the emergence of new treatments for cancer patients in an unprecedented time scale.

 

Le programme scientifique :

siric-vignette-adn   fleche-vert-droite-9x9 Program 1
DNA Damage Response (DDR)

Scientif coordinator(s):

Patricia Kannouche & Sophie Postel-Vinay


Aims:

To ensure the integrity of the genome and hence the fitness and viability of cells, DNA lesions that are formed as a result of various toxic assaults are normally repaired by an elaborate network of DNA damage response (DDR) pathways...Learn more
     
siric-vignette-immuno  

fleche-vert-droite-9x9Program 2
Immuno-Oncology

Scientif coordinator(s):

Laurence Zitvogel & Aurélien Marabelle

 

Aims :


The discovery of cancer immune checkpoints and the successes of immune- and tumor -targeted antibodies have changed the landscape of the clinical management of various malignancies...Learn more

     
siric-vignette-mm  

fleche-vert-droite-9x9 Program 3

Cancer Molecular Dynamics

 

Co-Headed by Pr Fabrice André and Dr Olivier Bernard
Aims:

 

Molecular medicine also called precision or personalized medicine is a scientific approach based on molecular analyses that drive methods for early diagnosis, and guidance for targeted therapies...Learn more